Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

Researchers at Eli Lilly and others published a phase II trial this week that combined semaglutide, the active ingredient in ...

With the rise in the use of weight loss medications, new questions are emerging about where the body positivity movement fits ...

Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

A scoop of pre-workout can feel like a shortcut to motivation, especially for teens and young adults juggling school, work, and training. But new findings from the Canadian Study of Adolescent ...

Obstructive sleep apnea induces a metabolic chain reaction that leads to increases in weight and blood sugar levels, among other unhealthy changes.

The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...

The weight-loss medications semaglutide (Wegovy) and tirzepatide (Zepbound) have been game changers for millions of Americans who want to shed extra pounds. New data from Gallup even suggests that ...

Fat-burning workouts don’t have to end in a puddle of sweat and tears. There are all kinds of ways to lose weight with exercise. Heck, you can even walk it off. In fact, if you’re at the beginning of ...

Feb 12 (Reuters) - Eli Lilly (LLY.N), opens new tab had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday, ahead of an expected decision ...